Alex Denner increased its stake in Intercept Pharmaceuticals Inc (ICPT) by 248.49% based on its latest 2018Q1 regulatory filing with the SEC. Sarissa Capital Management Lp bought 453,000 shares as the company’s stock rose 14.68% while stock markets declined. The hedge fund run by Alex Denner held 635,300 shares of the health care company at the end of 2018Q1, valued at $39.08 million, up from 182,300 at the end of the previous reported quarter. Sarissa Capital Management Lp who had been investing in Intercept Pharmaceuticals Inc for a number of months, seems to be bullish on the $2.42B market cap company. The stock decreased 1.45% or $1.2 during the last trading session, reaching $81.73. About 259,025 shares traded. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) has declined 38.34% since June 18, 2017 and is downtrending. It has underperformed by 50.91% the S&P500. Some Historical ICPT News: 08/05/2018 – Intercept Pharma at Deutsche Bank Conference Tomorrow; 04/04/2018 – INTERCEPT – EXPECTS NET SALES OF OCALIVA FOR QTR ENDED MARCH 31, TO BE SLIGHTLY LOWER THAN NET SALES OF OCALIVA FOR QTR ENDED DEC 31, 2017; 08/05/2018 – Intercept Pharmaceuticals Had Cash, Cash Equivalents and Investment Securities Available for Sale of $326.1M at March 31; 08/05/2018 – Intercept Pharmaceuticals Sees 2018 Worldwide Ocaliva Net Sales $170M-$185M; 05/04/2018 – Intercept Pharmaceuticals Announces Pricing of Upsized $250 Million Public Offering and Concurrent Private Placement of Common; 26/03/2018 – INTERCEPT PHARMA SAYS LAWSUIT WAS FILED BY A STOCKHOLDER OF CO ON AUG 4, 2017 – SEC FILING; 24/04/2018 – Intercept Pharmaceuticals Appoints Nancy Miller-Rich to Its Bd of Directors; 05/04/2018 – INTERCEPT REPORTS CONCURRENT PLACEMENT OF COMMON SHRS; 08/05/2018 – INTERCEPT PHARMA 1Q REV. $36.0M, EST. $38.9M; 02/05/2018 – Intercept Pharma Presenting at UBS Conference May 21
Bank Of The West decreased its stake in Whirlpool Corp (WHR) by 60.77% based on its latest 2018Q1 regulatory filing with the SEC. Bank Of The West sold 2,596 shares as the company’s stock declined 10.13% with the market. The institutional investor held 1,676 shares of the consumer electronics and appliances company at the end of 2018Q1, valued at $257,000, down from 4,272 at the end of the previous reported quarter. Bank Of The West who had been investing in Whirlpool Corp for a number of months, seems to be less bullish one the $10.69 billion market cap company. The stock decreased 0.72% or $1.1 during the last trading session, reaching $150.94. About 475,542 shares traded. Whirlpool Corporation (NYSE:WHR) has declined 16.26% since June 18, 2017 and is downtrending. It has underperformed by 28.83% the S&P500. Some Historical WHR News: 26/04/2018 – Whirlpool: Tender Offer Scheduled to Expire on May 23; 24/05/2018 – Whirlpool Corp Announces Preliminary Results of Modified Dutch Auction Tender Offer; 06/03/2018 – Two Sears Hometown Stores in California Refresh Appliance Retail Strategy; 08/05/2018 – Whirlpool Corp Enhances Voice Capabilities With Google Home in Connected Appliances; 17/04/2018 – Whirlpool Corporation Announces Annual Stockholders’ Meeting Results; 23/04/2018 – WHIRLPOOL REPORTS 4.5% QTR DIV INCREASE; 27/04/2018 – Whirlpool Closes Above 50-Day Moving Average: Technicals; 16/04/2018 – Whirlpool Raises Dividend to $1.15 Vs. $1.10; 17/04/2018 – Whirlpool at EuroCucina 2018: Four Exceptional Brands, One Vision of Excellence; 23/04/2018 – Whirlpool Misses EPS, Revenue Expectations — Earnings Review
Investors sentiment decreased to 0.88 in Q1 2018. Its down 0.05, from 0.93 in 2017Q4. It turned negative, as 51 investors sold WHR shares while 197 reduced holdings. 59 funds opened positions while 160 raised stakes. 59.81 million shares or 0.79% less from 60.28 million shares in 2017Q4 were reported. New Jersey Better Educational Savings invested in 0.34% or 2,000 shares. Tradition Cap Management Ltd Liability Corp stated it has 1.91% in Whirlpool Corporation (NYSE:WHR). Colonial has invested 0.5% in Whirlpool Corporation (NYSE:WHR). Sigma Planning Corporation holds 2,922 shares. 3,228 are owned by Perella Weinberg Partners Capital Mgmt L P. Cibc Markets Inc holds 0.02% or 32,626 shares in its portfolio. Exane Derivatives owns 489 shares. Gam Holding Ag invested in 0.02% or 4,496 shares. Wells Fargo & Communications Mn has invested 0.04% of its portfolio in Whirlpool Corporation (NYSE:WHR). York Mgmt Global Advsrs Ltd Limited Liability Company has invested 0.61% in Whirlpool Corporation (NYSE:WHR). Abner Herrman & Brock Ltd Liability Co holds 35,410 shares or 0.86% of its portfolio. Palladium Partners Ltd Liability Corporation reported 0.13% in Whirlpool Corporation (NYSE:WHR). 12,156 are held by State Of Alaska Department Of Revenue. Natl Pension owns 93,053 shares or 0.07% of their US portfolio. Bremer Trust Association holds 0.18% of its portfolio in Whirlpool Corporation (NYSE:WHR) for 4,065 shares.
Analysts await Whirlpool Corporation (NYSE:WHR) to report earnings on July, 25. They expect $3.86 earnings per share, up 15.22% or $0.51 from last year’s $3.35 per share. WHR’s profit will be $273.27M for 9.78 P/E if the $3.86 EPS becomes a reality. After $2.81 actual earnings per share reported by Whirlpool Corporation for the previous quarter, Wall Street now forecasts 37.37% EPS growth.
Since April 30, 2018, it had 0 buys, and 1 insider sale for $303,908 activity.
Among 10 analysts covering Whirlpool (NYSE:WHR), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Whirlpool had 36 analyst reports since August 13, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, February 4 by Goldman Sachs. The firm earned “Sell” rating on Wednesday, April 4 by Goldman Sachs. The firm has “Buy” rating given on Friday, April 1 by M Partners. As per Tuesday, October 24, the company rating was downgraded by RBC Capital Markets. Credit Suisse upgraded Whirlpool Corporation (NYSE:WHR) on Monday, June 4 to “Outperform” rating. The stock has “Buy” rating by M Partners on Monday, December 7. The rating was downgraded by Bank of America on Tuesday, October 24 to “Hold”. RBC Capital Markets maintained it with “Buy” rating and $22600 target in Monday, July 24 report. As per Monday, April 9, the company rating was maintained by Bank of America. RBC Capital Markets maintained it with “Top Pick” rating and $201 target in Monday, October 26 report.
Bank Of The West, which manages about $798.82 million US Long portfolio, upped its stake in Select Sector Spdr Tr (XLE) by 10,019 shares to 63,778 shares, valued at $4.30 million in 2018Q1, according to the filing. It also increased its holding in Bank New York Mellon Corp (NYSE:BK) by 6,757 shares in the quarter, for a total of 37,450 shares, and has risen its stake in Navient Corporation (NASDAQ:NAVI).
More notable recent Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) news were published by: Seekingalpha.com which released: “Intercept And Obeticholic Acid Therapy: Discerning Scientific Facts From Fallacies On Cholestatic Liver Diseases” on June 12, 2018, also Streetinsider.com with their article: “While Intercept (ICPT) NASH Competitor ‘Impresses’, ICPT Remains Ahead and is Undervalued – RBC” published on May 31, 2018, Fool.com published: “3 Top Biotech Stocks to Buy Right Now” on June 18, 2018. More interesting news about Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) were released by: Nasdaq.com and their article: “Intercept to Present at Upcoming Conference” published on May 20, 2018 as well as Seekingalpha.com‘s news article titled: “Intercept’s Obeticholic Acid Therapy And NASH: The Scientific Truth Is That Every Cloud Has A Silver Lining” with publication date: June 13, 2018.
Among 23 analysts covering Intercept Pharmaceuticals (NASDAQ:ICPT), 12 have Buy rating, 3 Sell and 8 Hold. Therefore 52% are positive. Intercept Pharmaceuticals had 74 analyst reports since August 10, 2015 according to SRatingsIntel. Oppenheimer maintained Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) on Monday, July 31 with “Buy” rating. BMO Capital Markets maintained the shares of ICPT in report on Thursday, February 15 with “Outperform” rating. The firm has “Outperform” rating by Wedbush given on Wednesday, February 24. Citigroup downgraded Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) on Friday, September 22 to “Neutral” rating. The firm has “Buy” rating given on Friday, July 21 by BMO Capital Markets. The firm earned “Sell” rating on Wednesday, February 7 by Goldman Sachs. JMP Securities downgraded Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) on Wednesday, October 4 to “Market Perform” rating. The firm has “Outperform” rating given on Tuesday, August 1 by BMO Capital Markets. JMP Securities maintained it with “Market Outperform” rating and $200 target in Tuesday, May 31 report. The rating was maintained by Wedbush with “Buy” on Thursday, February 1.
Investors sentiment decreased to 1.15 in 2018 Q1. Its down 0.16, from 1.31 in 2017Q4. It fall, as 24 investors sold ICPT shares while 35 reduced holdings. 20 funds opened positions while 48 raised stakes. 18.85 million shares or 4.89% more from 17.97 million shares in 2017Q4 were reported. Clearbridge Invests Lc, a New York-based fund reported 843 shares. Goldman Sachs Group has 141,487 shares for 0% of their portfolio. Daiwa Secs Grp has invested 0% of its portfolio in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Swiss Retail Bank invested in 0% or 30,500 shares. The Illinois-based Guggenheim Limited Liability Company has invested 0% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Federated Investors Pa reported 5,740 shares or 0% of all its holdings. Altrinsic Glob Advisors Ltd Liability Co has 0.93% invested in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) for 375,223 shares. Point72 Asset Management Limited Partnership owns 281,900 shares. 136,500 are owned by Spark Mgmt. Aperio Grp Incorporated has 0% invested in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) for 5,132 shares. Blackrock Inc invested in 0% or 1.28 million shares. Teacher Retirement Systems Of Texas holds 0% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) or 3,891 shares. 165,316 are held by Geode Mngmt Limited Com. Dekabank Deutsche Girozentrale reported 8,190 shares. Jane Street Grp Llc reported 0% in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT).